Page last updated: 2024-09-02

16-hydroxyestrone and 3,3'-diindolylmethane

16-hydroxyestrone has been researched along with 3,3'-diindolylmethane in 2 studies

Compound Research Comparison

Studies
(16-hydroxyestrone)
Trials
(16-hydroxyestrone)
Recent Studies (post-2010)
(16-hydroxyestrone)
Studies
(3,3'-diindolylmethane)
Trials
(3,3'-diindolylmethane)
Recent Studies (post-2010) (3,3'-diindolylmethane)
149172540916252

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bradlow, HL; Kotsopoulos, J; Llacuachaqui, M; Narod, SA; Nikitina, D; Sepkovic, D1
Altbach, M; Chalasani, P; Chow, HHS; Galons, JP; Huang, C; Maskarinec, G; Roe, DJ; Stopeck, A; Strom, MB; Thompson, PA; Thomson, CA; Wertheim, BC1

Trials

1 trial(s) available for 16-hydroxyestrone and 3,3'-diindolylmethane

ArticleYear
A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen.
    Breast cancer research and treatment, 2017, Volume: 165, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Double-Blind Method; Female; Humans; Hydroxyestrones; Indoles; Mammography; Middle Aged; Sex Hormone-Binding Globulin; Tamoxifen; Time Factors; Treatment Outcome

2017

Other Studies

1 other study(ies) available for 16-hydroxyestrone and 3,3'-diindolylmethane

ArticleYear
The effect of oral 3,3'-diindolylmethane supplementation on the 2:16α-OHE ratio in BRCA1 mutation carriers.
    Familial cancer, 2015, Volume: 14, Issue:2

    Topics: Administration, Oral; Adult; Female; Genes, BRCA1; Heterozygote; Humans; Hydroxyestrones; Indoles; Middle Aged; Mutation

2015